KKR & Co. Inc., a leading global investment firm, announces that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company. This strategic partnership will enable KKR to enhance its capabilities in biopharma royalty and credit investing, while expanding the firm’s existing footprint in the life sciences ecosystem. Founded in 2006 and headquartered in Stamford, Connecticut, HCRx has a strong track record of investing in commercial-stage and near-commercial-stage biopharmaceutical assets. Since inception, the firm has committed over $7 billion in capital and today manages approximately $3 billion in assets with a portfolio that spans over 10 therapeutic areas and over 55 products.
Read the full article: KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the Firm’s Health Care Franchise and Enhancing Its Life Sciences Strategy //
Source: https://www.businesswire.com/news/home/20250730161531/en/KKR-Announces-Strategic-Acquisition-of-HealthCare-Royalty-Partners-Expanding-the-Firms-Health-Care-Franchise-and-Enhancing-its-Life-Sciences-Strategy